View full meeting coverage »

Eyetube Meeting Coverage:

2018 World Ophthalmology Congress

 

Editorially Independent Content, Financially Supported by

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

The Latest BOULEVARD Trial Results

  Channels: Retina | Posted 6/20/2018

Arshad M. Khanini, MD, presents the results of the phase 2 BOULEVARD trial, which studied the efficacy of RG7716 in patients with diabetic macular edema. RG7716 is the first bispecific antibody designed for intravitreal use.


1 / 12 Series: 2018 World Ophthalmology Congress